IVERIC BIO/ US46583P1021 /

7/1/2022 9:59:52 PM	Chg. -0.24	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
9.39USD	-2.49%	84,904 Turnover: 798,075.03	-Bid Size: -	-Ask Size: -	957.54 mill.USD	0.00%	-

GlobeNewswire 2/22 Jeito Capital co-leads $65 million Series A financing in EyeBio

GlobeNewswire 12/3/2021 Akari Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Clinical Progr...

GlobeNewswire 11/16/2021 AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer

GlobeNewswire 3/17/2021 Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...

GlobeNewswire 12/12/2020 Annual Changes to the Nasdaq Biotechnology Index

GlobeNewswire 10/8/2020 Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Compa...

GlobeNewswire 3/26/2020 PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic

GlobeNewswire 7/24/2019 The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene...